All trademarks are the property of Zoetis Services LLC or
a related company or a licensor unless otherwise noted.
© 2017 Zoetis Services LLC. All rights reserved. CYT-00097R1
Indication: CYTOPOINT aids in the reduction of clinical signs associated with atopic dermatitis in dogs.
*Repeat administration every 4 to 8 weeks, as needed, in individual patients.
1
References: 1. Data on fi le, Study Report No. C863R-US-12-018, Zoetis Inc. 2. Gonzales AJ, Humphrey WR, Messamore JE, et al.
Interleukin-31: its role in canine pruritus and naturally occurring canine atopic dermatitis. Vet Dermatol. 2013;24(1):48-53.
doi:10.1111/j.1365-3164.2012.01098.x. 3. Data on fi le, Study Report No. C362N-US-13-042, Zoetis Inc. 4. Data on fi le,
Study Report No. C961R-US-13-051, Zoetis Inc.
Vet Dermatol . 2013;24(1):48-53.
Data on fi le, Study Report No. C362N-US-13-042, Zoetis Inc. 4. Data on fi le,
WEEKS OF
RELIEF
1
*
4
-
8 4 8
-
CYTOPOINT
®
provides fast, eff ective relief that helps improve the long-term
quality of life for dogs with atopic dermatitis and their families
1
TARGETED
Targets and neutralizes
interleukin (lL)-31, a key
itch-inducing cytokine in
atopic dermatitis
2
SAFE
Safe for dogs of all ages, even
those with concomitant
diseases, and can be used with
many common medications
3 ,4
WORKS FAST AND LASTS
Begins working within 1 day and
delivers 4 to 8 weeks of relief* from the
clinical signs of atopic dermatitis;
in-offi ce administration ensures compliance
1
To learn more, please visit www.CYTOPOINT.com
FROM ITCHY
AND ANGRY
TO IZZY
AND ANGIE
CELEBRATING ONE YEAR OF
ITCH-FREE HOLIDAYS...
AND EVERYDAYS!